Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- anakinra
- eliglustat
Interactions between your drugs
anakinra eliglustat
Applies to: anakinra, eliglustat
Anakinra may decrease the blood levels and effects of eliglustat. You may need a dose adjustment if you have been receiving eliglustat and are starting treatment with anakinra. Likewise, if you have been receiving both medications, the dose of eliglustat may need to be adjusted when anakinra is discontinued. Contact your doctor if your condition changes or you experience increased side effects. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
eliglustat food
Applies to: eliglustat
Do not consume grapefruit or grapefruit juice during treatment with eliglustat unless directed otherwise by your doctor. Grapefruit juice can increase the blood levels of eliglustat to dangerous levels. This may increase the risk of serious and potentially life-threatening cardiac side effects such as irregular heart rhythm, heart block, and cardiac arrest. Talk to your doctor if you have any questions or concerns. You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, shortness of breath, slow heart rate, weak pulse, or heart palpitations during treatment. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Kineret
Kineret is used to treat the symptoms of moderate to severe rheumatoid arthritis ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Ilaris
IIlaris (canakinumab) treats certain types of periodic fever syndromes, Still’s Disease, and gout f ...
Arcalyst
Arcalyst (rilonacept) is used to treat Cryopyrin-Associated Periodic Syndromes, Deficiency of ...
Rilonacept
Rilonacept is used for cryopyrin-associated periodic syndromes, familial cold autoinflammatory ...
Canakinumab
Canakinumab is used for cryopyrin-associated periodic syndromes, familial cold autoinflammatory ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.